Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Nishimura

Showing results (221-230 of 244) with videos related to

Pageof 25
Sort By:
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 9, 2019
Improving T Cell Receptor On-Target Specificity via Structure-Guided DesignLance M Hellman, Kendra C Foley, Nishant K Singh, et al.
Cancer Research|May 20, 2016
Feasibility of Telomerase-Specific Adoptive T-cell Therapy for B-cell Chronic Lymphocytic Leukemia and Solid MalignanciesSara Sandri, Sara Bobisse, Kelly Moxley, et al.
Oncotarget|November 21, 2017
Effective control of acute myeloid leukaemia and acute lymphoblastic leukaemia progression by telomerase specific adoptive T-cell therapySara Sandri, Francesco De Sanctis, Alessia Lamolinara, et al.
Cancer Immunology, Immunotherapy : CII|February 5, 2016
TCR gene-modified T cells can efficiently treat established hepatitis C-associated hepatocellular carcinoma tumorsTimothy T Spear, Glenda G Callender, Jeffrey J Roszkowski, et al.
Science (New York, N.Y.)|July 30, 2005
Recognition of host immune activation by Pseudomonas aeruginosaLicheng Wu, Oscar Estrada, Olga Zaborina, et al.
Journal for Immunotherapy of Cancer|September 12, 2024
Regression of renal cell carcinoma by T cell receptor-engineered T cells targeting a human endogenous retrovirusStefan Barisic, Elizabeth M Brahmbhatt, Elena Cherkasova, et al.
Nature Communications|November 24, 2022
A class-mismatched TCR bypasses MHC restriction via an unorthodox but fully functional binding geometryNishant K Singh, Jesus A Alonso, Jason R Devlin, et al.
Journal of Hematology & Oncology|April 9, 2017
Vaccination with poly(IC:LC) and peptide-pulsed autologous dendritic cells in patients with pancreatic cancerShikhar Mehrotra, Carolyn D Britten, Steve Chin, et al.
Science Advances|September 16, 2020
Identification of human CD4<sup>+</sup> T cell populations with distinct antitumor activityMichelle H Nelson, Hannah M Knochelmann, Stefanie R Bailey, et al.
Cell Reports|March 31, 2023
Targeting protein tyrosine phosphatases for CDK6-induced immunotherapy resistanceXueliang Gao, Yongxia Wu, Joel M Chick, et al.
Pageof 25

Showing results (221-230 of 244) with videos related to

Sort By:
Pageof 25
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 9, 2019
Improving T Cell Receptor On-Target Specificity via Structure-Guided DesignLance M Hellman, Kendra C Foley, Nishant K Singh, et al.
Cancer Research|May 20, 2016
Feasibility of Telomerase-Specific Adoptive T-cell Therapy for B-cell Chronic Lymphocytic Leukemia and Solid MalignanciesSara Sandri, Sara Bobisse, Kelly Moxley, et al.
Oncotarget|November 21, 2017
Effective control of acute myeloid leukaemia and acute lymphoblastic leukaemia progression by telomerase specific adoptive T-cell therapySara Sandri, Francesco De Sanctis, Alessia Lamolinara, et al.
Cancer Immunology, Immunotherapy : CII|February 5, 2016
TCR gene-modified T cells can efficiently treat established hepatitis C-associated hepatocellular carcinoma tumorsTimothy T Spear, Glenda G Callender, Jeffrey J Roszkowski, et al.
Science (New York, N.Y.)|July 30, 2005
Recognition of host immune activation by Pseudomonas aeruginosaLicheng Wu, Oscar Estrada, Olga Zaborina, et al.
Journal for Immunotherapy of Cancer|September 12, 2024
Regression of renal cell carcinoma by T cell receptor-engineered T cells targeting a human endogenous retrovirusStefan Barisic, Elizabeth M Brahmbhatt, Elena Cherkasova, et al.
Nature Communications|November 24, 2022
A class-mismatched TCR bypasses MHC restriction via an unorthodox but fully functional binding geometryNishant K Singh, Jesus A Alonso, Jason R Devlin, et al.
Journal of Hematology & Oncology|April 9, 2017
Vaccination with poly(IC:LC) and peptide-pulsed autologous dendritic cells in patients with pancreatic cancerShikhar Mehrotra, Carolyn D Britten, Steve Chin, et al.
Science Advances|September 16, 2020
Identification of human CD4<sup>+</sup> T cell populations with distinct antitumor activityMichelle H Nelson, Hannah M Knochelmann, Stefanie R Bailey, et al.
Cell Reports|March 31, 2023
Targeting protein tyrosine phosphatases for CDK6-induced immunotherapy resistanceXueliang Gao, Yongxia Wu, Joel M Chick, et al.
Pageof 25